The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Abstract
The hypoxia-inducible factors (HIFs) 1α and 2α are key mammalian transcription factors that exhibit dramatic increases in both protein stability and intrinsic transcriptional potency during low-oxygen stress. This increased stability is due to the absence of proline hydroxylation, which in normoxia promotes binding of HIF to the von Hippel–Lindau (VHL tumor suppressor) ubiquitin ligase. We now show that hypoxic induction of the COOH-terminal transactivation domain (CAD) of HIF occurs through abrogation of hydroxylation of a conserved asparagine in the CAD. Inhibitors of Fe(II)- and 2-oxoglutarate–dependent dioxygenases prevented hydroxylation of the Asn, thus allowing the CAD to interact with the p300 transcription coactivator. Replacement of the conserved Asn by Ala resulted in constitutive p300 interaction and strong transcriptional activity. Full induction of HIF-1α and -2α, therefore, relies on the abrogation of both Pro and Asn hydroxylation, which during normoxia occur at the degradation and COOH-terminal transactivation domains, respectively.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It was recently shown that HIFα association with p300 is blocked under normoxic conditions by hydroxylation of a conserved asparagine residue within the CAD (Lando et al. 2002).”
From FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) · cites this paper as Lando et al. 2002
In the citing paper
“As with HIF prolyl hydroxylases, endogenous HIF asparaginyl hydroxylase activity can be blocked with competitive inhibitors of 2-oxoglutarate and with iron chelators (Lando et al. 2002), suggesting that this enzyme might also resemble known hydroxylase enzymes.”
From FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) · cites this paper as Lando et al. 2002
In the citing paper
“HIF transcriptional activity is suppressed under normoxic conditions by hydroxylation of an asparagine residue within its C-terminal transactivation domain, blocking association with coactivators.”
From FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) · cites this paper as Lando et al. 2002
In the citing paper
“Full induction of the hypoxic response pathway upon exposure to low oxygen levels requires both stabilization of the HIFα transcription factor and activation of the CAD (Lando et al. 2002).”
From FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) · cites this paper as Lando et al. 2002
In the citing paper
“Asparagine hydroxylation is abrogated by hypoxia, allowing HIF to recruit the larger transcriptional apparatus to hypoxiaresponsive target genes (Lando et al. 2002).”
From FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) · cites this paper as Lando et al. 2002
In the citing paper
“This mechanism attenuates HIF transcriptional activity during early reoxygenation, acting as a buffer that limits the excessive metabolic activation and oxidative stress during the transition from hypoxia to normoxia”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [53]
In the citing paper
“FIH-1 functions at lower oxygen tensions than PHDs and hydroxylates a single asparagine residue within the C-terminal transactivation domain of HIF-1α, consequently limiting engagement of transcriptional co-activator complexes [52,53]”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [53]
In the citing paper
“Hif-1α is also hydroxylated in an oxygen-dependent reaction on a highly conserved asparagine residue by FIH-1 (Factor inhibiting HIF-1), which blocks the ability of Hif-1α to recruit transcriptional coactivators such as p300/CBP, in turn limiting transcriptional activation by Hif-1α under non-hypoxic conditions [45, 46].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [46]
Citations
Cites
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Mahon, P. C., Hirota, K., & Semenza, G. L. (2001) · Genes & Development · doi:10.1101/gad.924501 · Cited by 1,385
Tian, H., McKnight, S. L., & Russell, D. W. (1997) · Genes & Development · doi:10.1101/gad.11.1.72 · Cited by 1,351
Ema, M., Taya, S., Yokotani, N., Sogawa, K., Matsuda, Y., & Fujii-Kuriyama, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4273 · Cited by 1,016
HIF-1 and human disease: one highly involved factor
Semenza, G. L. (2000) · Genes & Development · doi:10.1101/gad.14.16.1983 · Cited by 909
Research works printed but not linked: 1
- Supplementary material is available on Science Online at www.sciencemag.org/cgi/content/full/295/5556/858/DC1
Cited by
Sorted by citations
Items 801–900 of 1,005
Henríquez, J. A., Sleeman, J. P., & Garvalov, B. K. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9930-x · Cited by 37
Yin, M.-B., Li, Z.-R., Tóth, K., Cao, S., Durrani, F. A., Hapke, G., Bhattacharya, A., Azrak, R. G., Frank, C., & Rustum, Y. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209073 · Cited by 37
Hu, Y., Zhao, Y., Li, P., Lu, H., Li, H., & Ge, J. (2023) · 中国科学通报：英文版 · doi:10.1016/j.scib.2023.07.032 · Cited by 37
Villar, D., Ortiz-Barahona, A., Gómez-Maldonado, L., Pescador, N., Sánchez‐Cabo, F., Hackl, H., Rodriguez, B. A. T., Trajanoski, Z., Dopazo, A., Huang, T. H. ‐., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045708 · Cited by 41
Chicooree, N., Unwin, R. D., & Griffiths, J. R. (2014) · Mass Spectrometry Reviews · doi:10.1002/mas.21421 · Cited by 36
MgcRacGAP Interacts with HIF-1α and Regulates its Transcriptional Activity
Lyberopoulou, A., Venieris, E., Mylonis, I., Chachami, G., Pappas, I. S., Simos, G., Bonanou, S., & Georgatsou, E. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000110460 · Cited by 36
Langhammer, S., Najjar, M., Hess‐Stumpp, H., & Thierauch, K. (2011) · Targeted Oncology · doi:10.1007/s11523-011-0184-7 · Cited by 36
HIF-2α regulates glyceraldehyde-3-phosphate dehydrogenase expression in endothelial cells
Graven, K. K., Bellur, D. L., Klahn, B. D., Lowrey, S. L., & Amberger, E. (2003) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(03)00049-6 · Cited by 36
Perceived hyperoxia: Oxygen-induced remodeling of the reoxygenated heart
Sen, C. K., Khanna, S., & Roy, S. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.01.003 · Cited by 36
Wang, X., Deng, J., Boyle, D. W., Zhong, J., & Lee, W. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000111482.43827.40 · Cited by 36
Tumor hypoxia is important in radiotherapy, but how should we measure it?
Brown, J. M., & Le, Q. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03936-6 · Cited by 36
Weiss, B., Allen, G. E., Kloehn, J., Abid, K., Jaquier-Gubler, P., & Curran, J. A. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab267 · Cited by 34
Exploration of the HIF-1α/p300 interface using peptide and Adhiron phage display technologies
Kyle, H. F., Wickson, K. F., Stott, J., Burslem, G. M., Breeze, A. L., Tiede, C., Tomlinson, D. C., Warriner, S. L., Nelson, A. S., Wilson, A. J., et al. (2015) · Molecular BioSystems · doi:10.1039/c5mb00284b · Cited by 35
Huang, Y., Ochieng, J. K., Kempen, M. B., Munck, A. B., Swagemakers, S. M. A., van IJcken, W. F. J., Grosveld, F. G., Tibboel, D., & Rottier, R. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057695 · Cited by 37
Hypoxia-Inducible Factors: Post-translational Crosstalk of Signaling Pathways
Dimova, E. Y., & Kietzmann, T. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-738-9_13 · Cited by 35
2-Oxoglutarate derivatives can selectively enhance or inhibit the activity of human oxygenases
Nakashima, Y., Brewitz, L., Tumber, A., Salah, E., & Schofield, C. J. (2021) · Nature Communications · doi:10.1038/s41467-021-26673-2 · Cited by 38
Iron and colorectal cancer: evidence from in vitro and animal studies
Padmanabhan, H., Brookes, M., & Iqbal, T. H. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuu015 · Cited by 35
Mayer, A., Höckel, M., & Vaupel, P. W. (2006) · Strahlentherapie und Onkologie · doi:10.1007/s00066-006-1525-9 · Cited by 36
Clauss, M. A., & Breier, G. (2005) · Birkhäuser Basel eBooks · doi:10.1007/b137088 · Cited by 36
Biju, M. P., Akai, Y., Shrimanker, N., & Haase, V. H. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00233.2005 · Cited by 35
Hassan, A. U., Arnold, B. M., Caine, S., Toosi, B. M., Verge, V. M. K., & Muir, G. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197486 · Cited by 34
FIH permits NAA10 to catalyze the oxygen-dependent lysyl-acetylation of HIF-1α
Kang, J., Chun, Y., Huh, J., & Park, J. (2018) · Redox Biology · doi:10.1016/j.redox.2018.09.002 · Cited by 34
Sánchez‐Navarro, A., Pérez‐Villalva, R., Murillo‐de‐Ozores, A. R., Martínez-Rojas, M. A., Rodríguez‐Aguilera, J. R., González, N., Castañeda‐Bueno, M., Gamba, G., Targa, F. R., & Bobadilla, N. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-88000-5 · Cited by 34
Elevated glucose increases genomic instability by inhibiting nucleotide excision repair
Ciminera, A. K., Shuck, S. C., & Termini, J. S. (2021) · Life Science Alliance · doi:10.26508/lsa.202101159 · Cited by 33
Liu, X., Du, H., Sun, Y., & Shao, L. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2072743 · Cited by 36
Minchenko, O. H., Opentanova, I. L., Ogura, T., Minchenko, D. O., Комісаренко, С. В., Caro, J., & Esumi, H. (2005) · Acta Biochimica Polonica · doi:10.18388/abp.2005_3402 · Cited by 33
Tang, Y., Schmitt-Ott, K., Qian, K.-P., Kagiyama, S., & Phillips, M. (2002) · Methods · doi:10.1016/s1046-2023(02)00231-1 · Cited by 36
Tsapournioti, S., Mylonis, I., Hatziefthimiou, A. A., Ιωάννου, Μ., Stamatiou, R., Koukoulis, G. K., Simos, G., Molyvdas, P., & Paraskeva, E. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24331 · Cited by 36
Ke, Q., Kluz, T., & Costa, M. (2005) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph2005010010 · Cited by 34
Fine tuning the HIF‐1 ‘global’ O2 sensor for hypobaric hypoxia in Andean high‐altitude natives
Hochachka, P. W., & Rupert, J. L. (2003) · BioEssays · doi:10.1002/bies.10261 · Cited by 34
Understanding hypoxia signalling in cells – a new therapeutic opportunity?
Ratcliffe, P. J. (2006) · Clinical Medicine · doi:10.7861/clinmedicine.6-6-573 · Cited by 33
Lee, P. W. T., Koseki, L. R., Haitani, T., Harada, H., & Kobayashi, M. (2024) · Cancers · doi:10.3390/cancers16091729 · Cited by 35
Shaikat, A. H., Azad, S. M. A. K., Tamim, M. A. R., Ullah, M. S., Amin, M. N., Sabbir, M. K., Tarun, M. T. I., Mostaq, M. S., Sabrin, S., Mahmud, M. Z., et al. (2025) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2025.07.003 · Cited by 37
Molecular imaging of tumor metabolism and apoptosis
Haberkorn, U., Markert, A., Mier, W., Askoxylakis, V., & Altmann, A. (2011) · Oncogene · doi:10.1038/onc.2011.169 · Cited by 33
Integration of hypoxic HIF-α signaling in blood cancers
Schito, L., Rey, S., & Konopleva, M. Y. (2017) · Oncogene · doi:10.1038/onc.2017.119 · Cited by 34
Olmos, G., Muñoz‐Félix, J. M., Mora, I., Muller, G. A., Ruiz‐Torres, M. P., López-Novoa, J. M., & Rodrı́guez-Puyol, D. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13319 · Cited by 33
Involvement of E3 Ligases and Deubiquitinases in the Control of HIF-α Subunit Abundance
Kubaichuk, K. I., & Kietzmann, T. (2019) · Cells · doi:10.3390/cells8060598 · Cited by 34
The inhibition of factor inhibiting hypoxia-inducible factor (FIH) by β-oxocarboxylic acids
Banerji, B., Conejo‐García, A., McNeill, L. A., McDonough, M. A., Buck, M. R., Hewitson, K. S., Oldham, N. J., & Schofield, C. J. (2005) · Chemical Communications · doi:10.1039/b510707e · Cited by 34
Jensen, R. L., Gillespie, D. L., House, P. A., Layfield, L. J., & Shelton, C. (2004) · Journal of neurosurgery · doi:10.3171/jns.2004.100.3.0488 · Cited by 32
Down-regulation of Hypoxia-inducible Factor-2 in PC12 Cells by Nerve Growth Factor Stimulation
Naranjo‐Suarez, S., Castellanos, M. C., Álvarez-Tejado, M., Vara, A., Landázuri, M. O., & del Peso, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304079200 · Cited by 33
Intestinal oxygen utilisation and cellular adaptation during intestinal ischaemia–reperfusion injury
Barakakis, P. A., Mavridis, T., Chlorogiannis, D., Barakakis, G., Laou, E., Sessler, D. I., Gkiokas, G., & Chalkias, A. F. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70136 · Cited by 32
Li, H., Ren, Y., Guo, S., Cheng, L., Wang, D., Yang, J., Chang, Z., & Zhao, X. (2008) · Journal of Experimental Zoology Part A Ecological Genetics and Physiology · doi:10.1002/jez.510 · Cited by 31
Gale, D. P., & Maxwell, P. H. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.10.012 · Cited by 32
Cold shock protein YB-1 is involved in hypoxia-dependent gene transcription
Rauen, T., Frye, B. C., Wang, J., Raffetseder, U., Alidousty, C., En‐Nia, A., Floege, J., & Mertens, P. R. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.064 · Cited by 32
Structural and functional analysis of coral Hypoxia Inducible Factor
Zoccola, D., Morain, J., Pagès, G., Caminiti-Segonds, N., Giuliano, S., Tambutté, S., & Allemand, D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186262 · Cited by 34
Zhang, Z., Shi, C., & Wang, Z. (2023) · Nutrients · doi:10.3390/nu15132833 · Cited by 34
Santana‐Blank, L. A., Rodríguez–Santana, E., & Santana‐Rodríguez, K. E. (2005) · Photomedicine and Laser Surgery · doi:10.1089/pho.2005.23.416 · Cited by 32
Tan, T., Yu, R. M. K., Wu, R. S. S., & Kong, R. Y. C. (2017) · Gene Regulation and Systems Biology · doi:10.1177/1177625017713193 · Cited by 32
Hypoxia-inducible factor 1 proteomics and diving adaptations in ringed seal
Johnson, P., Elsner, R., & Zenteno‐Savín, T. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.03.008 · Cited by 32
Biochemistry of the hypoxia-inducible factor hydroxylases
Fiorini, G., & Schofield, C. J. (2024) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2024.102428 · Cited by 33
Molecular Biology of Renal Cortical Tumors
Klatte, T., & Pantuck, A. J. (2008) · Urologic Clinics of North America · doi:10.1016/j.ucl.2008.07.006 · Cited by 31
Preclinical Evaluation of Discorhabdins in Antiangiogenic and Antitumor Models
Harris, E. M., Strope, J. D., Beedie, S., Huang, P. A., Goey, A. K. L., Cook, K. M., Schofield, C. J., Chau, C. H., Cadelis, M. M., Copp, B. R., et al. (2018) · Marine Drugs · doi:10.3390/md16070241 · Cited by 31
CITED2 and the modulation of the hypoxic response in cancer
Fernandes, M. T., Calado, S. M., Mendes-Silva, L., & Bragança, J. (2020) · World Journal of Clinical Oncology · doi:10.5306/wjco.v11.i5.260 · Cited by 30
Crispo, F., Pietrafesa, M., Condelli, V., Maddalena, F., Bruno, G., Piscazzi, A., Sgambato, A., Esposito, F., & Landriscina, M. (2020) · Molecules · doi:10.3390/molecules25163754 · Cited by 32
Mao, S., Liu, Y., Morgan, J. B., Jekabsons, M. B., Zhou, Y., & Nagle, D. G. (2009) · Journal of Natural Products · doi:10.1021/np900444m · Cited by 31
Factor‐inhibiting HIF‐1 (FIH‐1) is required for human vascular endothelial cell survival
Kiriakidis, S., Henze, A., Kruszynska‐Ziaja, I., Skobridis, K., Theodorou, V., Paleolog, E. M., & Mazzone, M. (2015) · The FASEB Journal · doi:10.1096/fj.14-252379 · Cited by 32
Grow₂: the HIF system, energy homeostasis and the cell cycle.
Moniz, S., Biddlestone, J., & Rocha, S. (2014) · PubMed · doi:10.14670/hh-29.10.589 · Cited by 30
Bozova, S., & Elpek, G. Ö. (2007) · Apmis · doi:10.1111/j.1600-0463.2007.apm_610.x · Cited by 31
Hypoxic Regulation of NF‐κB Signaling
Cummins, E. P., Comerford, K. M., Scholz, C. C., Brüning, U., & Taylor, C. T. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35025-8 · Cited by 31
Pierre, C. C., Longo, J., Bassey-Archibong, B. I., Hallett, R. M., Milosavljevic, S., Beatty, L., Hassell, J. A., & Daniel, J. M. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.10.018 · Cited by 30
Stoehr, A., Yang, Y., Patel, S., Evangelista, A. M., Aponte, A. M., Wang, G., Liu, P., Boylston, J. A., Kloner, P. H., Lin, Y., et al. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw081 · Cited by 29
Taylor, S. E., Bagnall, J., Mason, D. Y., Lévy, R., Fernig, D. G., & Sée, V. (2016) · Open Biology · doi:10.1098/rsob.160195 · Cited by 29
When the Brain Yearns for Oxygen
Leu, T., Schützhold, V., Fandrey, J., & Ferenz, K. B. (2019) · Neurosignals · doi:10.33594/000000199 · Cited by 31
Advances in antitumor research of HIF-1α inhibitor YC-1 and its derivatives
Ouyang, C., Zhang, J., Lei, X., Xie, Z., Liu, X., Li, Y., Huang, S., Wang, Z., & Tang, G. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106400 · Cited by 30
The Antioxidant Quercetin Inhibits Cellular Proliferation via HIF-1-Dependent Induction of p21WAF
Bach, A., Bender–Sigel, J., Schrenk, D., Flügel, D., & Kietzmann, T. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.3000 · Cited by 30
Oxygen tension level and human viral infections
Morinet, F., Casetti, L., François, J.-H., Capron, C., & Pillet, S. (2013) · Virology · doi:10.1016/j.virol.2013.06.018 · Cited by 30
Engineering Stem Cells for Biomedical Applications
Yin, P. T., Han, E. X., & Lee, K. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201400842 · Cited by 31
Lee, S., & Goldfinger, L. E. (2014) · The FASEB Journal · doi:10.1096/fj.14-255711 · Cited by 30
Hipoxia tumoral. Papel del factor inducible por hipoxia
Fraga, A. M., Ribeiro, R. J. T., & Medeiros, R. (2009) · Actas Urológicas Españolas · doi:10.1016/s0210-4806(09)72891-8 · Cited by 37
Willam, C., Nicholls, L. G., Ratcliffe, P. J., Pugh, C. W., & Maxwell, P. H. (2004) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2003.11.017 · Cited by 31
Chen, K., Gan, Y., Gumireddy, K., Li, A., Yao, W., Gao, L., Chen, S., Hao, J., Wang, J., Huang, Q., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3134 · Cited by 29
Datta, K., Li, J., Karumanchi, S. A., Wang, E., Rondeau, É., & Mukhopadhyay, D. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00910.x · Cited by 29
Zhang, F., Shen, G., Liu, X., Wang, F., Zhao, H.-L., Yu, J., & Zhang, J. (2011) · Biochemistry · doi:10.1021/bi101585c · Cited by 28
Revisiting the role of hypoxia-inducible factors in pulmonary hypertension
Shimoda, L. A., Yun, X., & Sikka, G. (2019) · Current Opinion in Physiology · doi:10.1016/j.cophys.2018.12.003 · Cited by 29
Developmental Regulation of Oxygen Sensing and Ion Channels in the Pulmonary Vasculature
Cornfield, D. N. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-60761-500-2_13 · Cited by 28
Baby, S. M., Roy, A., Mokashi, A., & Lahiri, S. (2003) · Histochemistry and Cell Biology · doi:10.1007/s00418-003-0588-2 · Cited by 29
Saito, K., Adachi, N., Koyama, H., & Matsushita, M. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.06.015 · Cited by 29
Wilkins, S. E., Karttunen, S., Hampton‐Smith, R. J., Murchland, I., Chapman‐Smith, A., & Peet, D. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.294678 · Cited by 29
Self-citationCatalytic mechanism and substrate specificity of HIF prolyl hydroxylases
Smirnova, N. A., Hushpulian, D. M., Speer, R. E., Gaisina, I. N., Ratan, R. R., & Gazaryan, I. G. (2012) · Biochemistry (Moscow) · doi:10.1134/s0006297912100033 · Cited by 31
USP9X destabilizes pVHL and promotes cell proliferation
Zhang, C., Peng, Z., Zhu, M., Wang, P., Du, X., Li, X., Liu, Y., Jin, Y., McNutt, M. A., & Yin, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.11139 · Cited by 29
Gruneberg, D., Montellano, F. A., Plaschke, K., Li, L., Marti, H. H., & Kunze, R. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.10.001 · Cited by 29
Linke, S., Hampton‐Smith, R. J., & Peet, D. J. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35004-0 · Cited by 29
Self-citationvan den Beucken, T., Magagnin, M. G., Savelkouls, K. G. M., Lambin, P., Koritzinsky, M., & Wouters, B. G. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.04.026 · Cited by 29
Sun, X., Kanwar, J. R., Leung, E. Y., Vale, M., & Krissansen, G. W. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302118 · Cited by 29
Rusconi, F., Guillonneau, F., & Praseuth, D. (2002) · Mass Spectrometry Reviews · doi:10.1002/mas.10036 · Cited by 29
Davidson, T. L., Salnikow, K., & Costa, M. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.6.1485 · Cited by 29
Role of HIF in fish inflammation
Shi, X., Gao, F., Zhao, X., Pei, C., Zhu, L., Zhang, J., Li, C., Li, L., & Kong, X. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.109222 · Cited by 28
Fingerprint of the oxido-reductase ERO1: A protein disulfide bond producer and supporter of cancer
Zito, E., Guarrera, L., & Janssen-Heininger, Y. M. W. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189027 · Cited by 28
A novel regulation of VEGF expression by HIF‐1α and STAT3 in HDM2 transfected prostate cancer cells
Rathinavelu, A., Narasimhan, M., & Muthumani, P. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01472.x · Cited by 28
The transition state structure for binding between TAZ1 of CBP and the disordered Hif-1α CAD
Lindström, I., Andersson, E., & Dogan, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-26213-x · Cited by 28
Monoclonal Antibody-Based Screening Assay for Factor Inhibiting Hypoxia-Inducible Factor Inhibitors
Lee, S.-H., Moon, J. H., Cho, E. A., Ryu, S.-E., & Lee, M. K. (2008) · SLAS DISCOVERY · doi:10.1177/1087057108318800 · Cited by 29
Singh, M., Devi, U., Roy, S., Gupta, P. S., Saraf, S. A., & Kaithwas, G. (2016) · Breast Cancer · doi:10.1007/s12282-016-0683-6 · Cited by 28
(2003) · CRC Press eBooks · doi:10.1201/b14819-12 · Cited by 29
Zhu, Y., Wang, J., Meng, X., Xie, H., Tan, J., Guo, X., Han, P., & Wang, R. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13264 · Cited by 28
HIF prolyl hydroxylase inhibition augments dopamine release in the rat brain in vivo
Witten, L. M., Sager, T. N., Thirstrup, K., Johansen, J. L., Larsen, D. B., Montezinho, L. P., & Mørk, A. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21988 · Cited by 28
Muir, C., Chung, L. W. K., Carson, D. D., & Farach‐Carson, M. C. (2006) · Clinical & Experimental Metastasis · doi:10.1007/s10585-006-9021-2 · Cited by 32
Hypoxia in Skin Cancer: Molecular Basis and Clinical Implications
Jeon, S., Jeon, M., Choi, S., Yoo, S., Park, S.-H., Lee, M., & Kim, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054430 · Cited by 28
Intracellular EP2 prostanoid receptor promotes cancer-related phenotypes in PC3 cells
Fernández‐Martínez, A. B., & Lucio-Cazaña, F. J. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1891-5 · Cited by 27
Kaluz, Š., Kaluzová, M., & Stanbridge, E. J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21644 · Cited by 27
Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
Taneja, S., Vetter, S. W., & Leclerc, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158153 · Cited by 28
Metadata
- Authors
- Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L.
- Affiliations
- Adelaide University (AU)
- Commonwealth Scientific and Industrial Research Organisation (AU)
- Corresponding author
- Whitelaw, Murray L.
- Venue
- Science
- Published
- 2002-02
- Volume
- 295
- Issue
- 5556
- Pages
- 858-861
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1973092951
- Semantic Scholar
- 56986a3761858ed94221534104f97dacadfc3a98
- Cited by
- 1,558
- References
- 28
- Citations by year
- 2026: 25 · 2025: 31 · 2024: 34 · 2023: 46 · 2022: 46 · 2021: 48 · 2020: 43 · 2019: 50 · 2018: 50 · 2017: 48 · 2016: 58 · 2015: 58 · 2014: 58 · 2013: 67 · 2012: 58
- FWCI
- 49.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- hypoxia-inducible factor, HIF-1α, HIF-2α, proline hydroxylation, transactivation domain, p300 coactivator, protein stability, 2-oxoglutarate-dependent dioxygenase, transcriptional activation, hypoxia
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Amino Acid Sequence, Animals, Asparagine, Cell Line, Humans, Mixed Function Oxygenases, Hydroxylation, Molecular Sequence Data, Mutation, Oxygen, Proline, Recombinant Fusion Proteins, Mass Spectrometry, Transcription Factors, Transcriptional Activation, Trans-Activators, Cell Hypoxia, Protein Structure, Tertiary, Amino Acid Substitution, Mice, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
